CJC-1295 w DAC 5mg
CJC-1295 with DAC is a synthetic tetrasubstituted peptide analog supplied as a high-purity lyophilized powder for laboratory research applications. This research-grade CJC-1295 with DAC 5mg vial is manufactured under strict quality control standards and analytically verified to ensure purity, identity, and batch consistency. CJC-1295 with DAC is widely referenced in scientific literature examining growth hormone–releasing hormone (GHRH) receptor interaction and peptide-mediated endocrine signaling pathways in controlled experimental environments.
Structurally designed as a modified analog of growth hormone–releasing hormone (GHRH), CJC-1295 incorporates Drug Affinity Complex (DAC) technology to extend its half-life in research models. The DAC modification enables prolonged binding to circulating proteins, supporting extended activity duration within experimental frameworks. Researchers studying GHRH receptor dynamics and peptide-receptor signaling frequently reference CJC-1295 with DAC in laboratory models examining receptor activation patterns, signaling cascade modulation, and molecular response timing.
The 5mg CJC-1295 with DAC peptide is provided in lyophilized powder form to preserve structural integrity and support long-term stability. Lyophilization removes moisture under controlled freeze-drying conditions, helping maintain peptide conformation and minimize degradation during storage. This preservation method is widely utilized in peptide research to enhance shelf life and ensure reproducibility across laboratory applications. Each production batch undergoes analytical testing to confirm ≥99% purity, ensuring consistent material quality suitable for scientific investigation.
CJC-1295 with DAC remains a compound of interest in endocrine and receptor-signaling research due to its structural modification and extended stability profile. Researchers exploring peptide-mediated hormone signaling pathways, receptor engagement kinetics, and synthetic analog compounds frequently include CJC-1295 with DAC in controlled experimental models. Its receptor-targeting design and prolonged activity characteristics contribute to its continued evaluation in advanced laboratory research environments.
Each vial contains 5mg of CJC-1295 with DAC as a white to off-white lyophilized powder. For optimal stability, store at -20°C under appropriate laboratory conditions and protect from excessive heat, light exposure, and repeated freeze-thaw cycles to preserve compound integrity.
This CJC-1295 with DAC 5mg vial is supplied for laboratory research applications and intended for use by qualified professionals conducting controlled experimental studies involving synthetic GHRH analog peptides.
